Ardonagh Specialty appoints Amy Goldenberg as Global Commercial Director
Ardonagh Specialty has appointed Amy Goldenberg to the newly created position of Global Commercial Director.
Goldenberg will be responsible for business development, focussing on organic growth and cross-selling initiatives, and creating an international key account strategy for new business production and major client retention.
She joins from Gallagher Specialty, where she established a business development function and led bid, marketing, sales and research teams to support six major divisions, including Aerospace, Marine, Construction, Energy and Renewables, Financial Risks and Property & Casualty. Before that she spent a decade at JLT Specialty in various roles, including Head of Global Mining and Senior Consultant in its Credit, Political and Security Risk division.
Based in London, Goldenberg will report to Chief Investment Officer Nabila Leather.
Nabila Leather said: “At Ardonagh Specialty we have ambitious growth plans, and Amy will be a key player in helping us achieve them. She brings with her a wealth of experience not just in business development and strategy but in change management, people management and frontline trading - with technical knowledge across a real mix of London Market products. She understands exactly how a business development function should be structured to maximise impact, and she’s the perfect person to help us clarify our offering, solidify our operations, and promote our services as a credible, agile and responsive alternative to other big-listed brokerages.”
Amy Goldenberg said: “I’m not someone who likes to sit back and accept the status quo, so I was attracted to the energy of Ardonagh Specialty - and its genuine passion to want to get things done and do things better really resonated with me.
“Ardonagh Specialty is a highly ambitious organisation with an abundance of opportunity - I hope to bring fresh insight that will help the Specialty business continue to build out and strengthen its global proposition. There’s been considerable change over the past few months, and there’s lots to observe and absorb. I’m looking forward to getting to know the trading teams, getting into the detail of how they work in partnership with clients, and getting in place the structures and resources that will allow even greater commercial goals and objectives to be achieved.”
Ardonagh Specialty Ardonagh Specialty is the holding company and growth platform for leading independent brokers Bishopsgate, Inver Re and Price Forbes. Combined, we have 1400 colleagues globally and manage over $7 billion in gross written premium. With a strong presence and deep relationships worldwide, and a steadfast commitment to investing in the best people, markets and technology, together our businesses offer open market programmes, reinsurance and international solutions designed to empower clients to achieve their strategic ambition.
The Ardonagh Group
The Ardonagh Group is the UK’s largest independent insurance distribution platform and a top 20 broker globally. We are collection of best-in-class entrepreneurial and specialist brands with a network of more than 100 locations and a combined workforce of more than 10,000 people. Across our portfolio, we offer a highly diversified range of insurance-related products and services across the full insurance value chain in the UK, Ireland and broader international markets. From complex multinational corporations to individuals purchasing personal insurance policies, our understanding of the communities we serve, together with our scale and breadth, allows us to work with our insurer partners to deliver a broad range of product and risk solutions that meet customer needs. For more information, visit our website: www.ardonagh.com.
Patrick Rastiello joins Ardonagh Specialty to lead North America Reinsurance expansion
Ardonagh Specialty has appointed Patrick Rastiello as CEO* of its North American reinsurance operations.
Introducing ACT’s new partnership with global charity, Médecins Sans Frontières
ACT’s board of Trustees are delighted to officially announce a new partnership with global humanitarian charity, Médecins Sans Frontières. This incredible organisation provides vital medical care in communities around the world where others cannot, or will not, go. Spanning over more than 70 countries, they act with total impartiality to save people’s lives in conflict zones, natural disasters and epidemics.